US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE BREST, UNIVERSITE BRETAGNE OCCIDENTALE, INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNMENT, ETABLISSEMENT FRANCAIS DU SANG (EFS) on April 15 for "Methods for predicting the risk of developing pulmonary colonization/infection by Pseudomonas aeruginosa" (French Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,276,000, issued on April 15, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris), CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE BREST (Brest, France), UNIVERSITE BRETAGNE OCCIDENTALE (Brest, France), INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNMENT (Paris) and ETABLISSEMENT FRANCAIS DU SANG (EFS) (La Plaine Saint Denis, France).

"Methods for predicting the risk of developing pulmonary colonization/infection by Pseudomonas aeruginosa" was invented by Genevieve Hery-Arnaud (Brest, France), Jerome Mounier (Plouzane, France), Charles-Antoine Guilloux (Brest, France), Patricia Lepage (Jouy-en-Josas, France), Stanislas...